Patients 3 ways to make 2024 the year of the patient Clinical research is never just about the next year; it's always about the next several years.
Digital Retaining the human element of AI within pharma and healthca... Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?
Partner Content Partner Content The ryze-elluminate integration to maximise automation in cl... The ryze-elluminate integration
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
